Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVEFENACIN vs RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REVEFENACIN vs RIBOCICLIB: Safety Overview

Metric REVEFENACIN RIBOCICLIB
Total FAERS Reports 280 27,997
Deaths Reported 11 4,501
Death Rate 3.9% 16.1%
Hospitalizations 23 6,700
Average Patient Age 72.4 yrs 60.2 yrs
% Female Patients 59.1% 99.0%
FDA Approval Date Nov 9, 2018 Mar 13, 2017
Manufacturer Viatris Specialty LLC Novartis Pharmaceuticals Corporation
Route RESPIRATORY (INHALATION) ORAL
Marketing Status Prescription Prescription